Recursion Pharmaceuticals
RXRX
#5083
Rank
A$2.62 B
Marketcap
A$4.21
Share price
3.86%
Change (1 day)
-34.14%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): A-$1.31

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$1.34. In 2025 the company made an earnings per share (EPS) of A-$2.21 an increase over its 2024 EPS that were of A-$2.47.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.31-40.6%
2025A-$2.21-10.84%
2024A-$2.475.73%
2023A-$2.3414.6%
2022A-$2.0417.39%
2021A-$1.74